ReviewThe FEBS journal2026
Membrane-type I metalloproteinase (MT1-MMP): A key modifier of extracellular matrix microenvironment.
Review in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- In Vitro Anti-Aging Properties of aMolecules (Basel, Switzerland) · 2026Article
- When proteases reshape barriers: Basement membrane remodelling in development, wound healing and tumour progression.The FEBS journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular matrix (ECM) is a major component of the cellular microenvironment. It holds cells, directly sends signals to the cells, pools growth factors and cytokines, and guides cell migration and differentiation. A type I transmembrane proteinase, membrane-type I matrix metalloproteinase (MT1-MMP/MMP14), degrades ECM at the cell surface and cleaves cell surface receptors, thereby modifying cellular behavior. It is a major promoter of cell invasion and tissue destruction in diseases, such as cancer and arthritis, and is a crucial enzyme that maintains fibrillar collagen homeostasis in stromal tissue. This review discusses the current understanding of the function and regulation of this important cell surface proteinase in health and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.